Tag:
chronic kidney disease
Latest Headlines
Latest Headlines
UPDATED: Amgen snags KAI Pharma's CKD program in $315M buyout
In the latest in a string of biotech acquisitions, Amgen says it is buying KAI Pharmaceuticals for $315 million in cash.
Could kidney damage biomarkers speed drug development?
Drug-induced kidney injury is an important issue for patients, and current biomarkers can bring up false positives, causing drug developers to abandon projects too early. A new collaboration will
Elevated hormone FGF23 could indicate kidney failure imminent
Researchers have found a hormone that, if elevated, could catch kidney failure before it happens. But, first, a little background on phosphorus. Just enough phosphorus in our bodies is a good thing.
Three-biomarker combo may better predict kidney failure
Researchers at the San Francisco VA Medical Center think they have found a better way to predict risk of kidney failure and death with a combined use of three biomarkers. Currently, chronic kidney
Biomarkers help ID those at risk of developing CKD
Measuring three biomarkers from a single blood sample may help doctors identify patients who are at high risk of developing chronic kidney disease, according to data from a 2,345-patient study
